Market Access Analytics and Insight
Our Market Research & Analysis service is uniquely tailored for…
Our Market Research & Analysis service is uniquely tailored for…
Leading in market access, Strategy Development from Health Analytical Solutions…
Diagnostics have woven themselves into the fabric of patient care within the NHS, becoming an indispensable part of the healthcare journey. As these diagnostic procedures increasingly become the linchpin in patient pathways, any bottleneck within this area could significantly impact the overall healthcare delivery system.
This piece delves into the pressing need to reassess diagnostic demands, capacities, and capabilities. It's crucial to understand the factors driving the surge in diagnostic procedures and how innovations in medical technology could streamline patient pathways, potentially reducing wait times and the necessity for repeated scans.
The integration of cutting-edge medical technology holds the potential to revolutionize patient diagnostics. By introducing more efficient technologies, we could see a reduction in pathway lengths and a decrease in the need for repeat diagnostics as patients endure lengthy waits for treatment.
As of May 2018, nearly half a million patients faced wait times exceeding 18 weeks, with a total of 4.1 million patients on waiting lists. This backlog raises a critical question: will this lead to an increase in diagnostic procedures due to the need for updated scans?
The fiscal year of 2017/18 saw over 21 million diagnostic scans conducted, signifying that one in every six secondary care events involved a diagnostic scan. A comparison with the 2013/14 period reveals a consistent scan rate but with an additional 344,000 patients scanned in April 2018 compared to April 2013. This uptick begs the question of whether our current system can meet the growing demand.
The financial aspect of diagnostic scans is staggering, with more than £789 million allocated to NHS Trusts and independent providers for diagnostics in 2016-17. However, the actual cost to deliver these services exceeded £933 million, indicating a significant shortfall. This discrepancy underscores the urgent need for a strategic reevaluation of how diagnostics are funded and managed within the NHS.
The ongoing surge in diagnostic demand, compounded by financial constraints, highlights the necessity for a comprehensive review of diagnostic services. It's time to critically assess the equipment, true capacity, and the most effective ways to deliver diagnostic services that prioritise patient outcomes.
At Health Analytical Solutions, we possess the expertise to dissect complex data, identifying pathways with disproportionate diagnostic-to-surgery ratios. Our aim is to pinpoint areas ripe for improvement, thereby enhancing patient care efficiency.
If you're intrigued by our insights and eager to explore how we can illuminate the path to better diagnostic efficiency, we invite you to reach out. Your engagement can propel this vital conversation forward.
As we anticipate our next discussion on the evolving landscape of Urology within the NHS, we encourage you to connect with us on LinkedIn or follow us on Twitter. Let's navigate the future of healthcare together.
© Health Analytical Solutions 2025